California biotech company Cellipont has opened a new 76,000 square foot cell therapy headquarters in The Woodlands' booming ...

Menopause can bring a wave of physical and emotional changes—and for people with cancer, those changes can start earlier or ...

Amtagvi monotherapy achieved a 25.6% objective response rate and 71.8% disease control rate in NSCLC patients without ...

He was told cancer would kill him in two to four years. Fourteen years later, he credits a series of medications and ...

Neuroblastoma RAS viral oncogene homolog (NRAS)-mutant melanoma is an aggressive form of skin cancer that develops because of ...

In late September, oncology experts gathered in Nashville, Tennessee, for the 2025 Patient-Centered Oncology Care ® conference. Over 2 days, 15 panel discussions explored topics aligned with this year ...

Local researchers are leading cutting-edge immunotherapy programs that are transforming patient care in B.C. and beyond ...

Throughout October, CURE highlighted research developments and evolving treatment strategies that continue to shape cancer ...

A new pancreatic cancer therapy targets sugar molecules on cell surfaces, offering hope where traditional immunotherapies ...

The results of a late-stage drug trial released Thursday are raising hopes that type 1 diabetes patients with chronic kidney ...

The latest national report of the American Lung Association 2025: State of Lung Cancer Report was published on Nov 5, 2025, ...

Doctor after doctor misdiagnosed or shrugged off Ruth Wilson’s rashes, swelling, fevers and severe pain for six years. She ...